Results of a new study, presented at the European League Against Rheumatism (EULAR) Congress 2016, suggest that a single infusion of the anti-CD20 antibody rituximab (Rituxan, Genentech, Inc) can delay the onset of rheumatoid arthritis for up to one year, in people at high risk of developing the disease. Continue reading
Researchers at the University of Cincinnati (UC) in US, are conducting a new clinical trial of a non-drug approach for treating fibromyalgia with the use of a proprietary electrode-emitting headband device called Cefaly, which is currently used for treating migraine headaches. The trial will assess the devices potential therapeutic effect on people with fibromyalgia. Continue reading
Researchers at the University College London (UCL) have discovered that the widely used anti-inflammatory drug HUMIRA, doesn’t just work by inhibiting its target protein, TNF, but also by enhancing a particular function of TNF in rheumatoid arthritis patients.
The study, which was published in The Journal of Experimental Medicine, may help explain the divergent efficacies of different TNF-targeting drugs. Continue reading
A new study, published in BMJ Open, suggests that between a third and half of the UK population (43%) lives with chronic pain, which is roughly 28 million adults. The researchers analysed studies on population-based estimates of chronic pain – defined as lasting more than three months – chronic widespread pain, fibromyalgia, and chronic neuropathic pain. Continue reading
Just before British astronaut Tim Peake returned to earth recently, he received a very special letter from the President of the National Osteoporosis Society, Her Royal Highness The Duchess of Cornwall, who wrote to thank him for his health in research into the condition during him time in space. Continue reading